Anal intraepithelial neoplasia;Neoplasia intraepitelial anal

Medicina Clinica

Volumn 127, Issue 19, 2006, Pages 749-755

  Parés, David ^a   Mullerat, José ^b   Pera, Miguel ^a  

^a HOSPITAL DEL MAR   (Spain)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Anal intraepithelial neoplasia; Diagnosis; Follow up; Human papillomavirus; Treatment

Indexed keywords

IMIQUIMOD;

ANAMNESIS; ANUS TUMOR; CANCER SCREENING; CANCER SURGERY; CONDYLOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MEDICAL EDUCATION; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; UTERINE CERVIX CANCER;

EID: 33845928728     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095527     Document Type: Review

References (58)

1. Muñoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol. 2000;19:1-5.
2. Congilosi SM, Madoff RD. Current therapy for recurrent and extensive anal warts. Dis Colon Rectum. 1995;38:1101-7.
3. Palefsky JM, Holly EA, Gonzales J, Berline J, Ahn DK, Greenspan JS. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 1991;51:1014-9.
4. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med. 2000;342:792-800.
5. Fenger C, Nielsen VT. Dysplastic changes in the anal canal epithelium in minor surgical specimens. Acta Pathol Microbiol Scand. 1981;89:463-5.
6. McCance DJ, Clarkson PK, Dyson JL, Walker PG, Singer A. Human papillomavirus types 6 and 16 in multifocal intraepithelial neoplasias of the female lower genital tract. Br J Obstet Gynaecol. 1985;92:1093-100.
7. Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg. 2005;92:1133-6.
8. Palefsky JM. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol. 2000;27:471-9.
9. Shah KV. Human papillomaviruses and anogenital cancers. N Engl J Med. 1997;337:1386-8.
10. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004;101:270-80.
11. Scholefield JH, Sonnex C, Talbot IC, Palmer JG, Whatrup C, Mindel A, et al. Anal and cervical intraepithelial neoplasia: possible parallel. Lancet. 1989;2:765-9.
12. Abbasakoor F, Boulos PB. Anal intraepithelial neoplasia. Br J Surg. 2005;92:277-90.
13. Frisch M, Glimelius B, Van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337:1350-8.
14. Sonnex C, Scholefield JH, Kocjan G, Kelly G, Whatrup C, Mindel A, et al. Anal human papillomavirus infection: a comparative study of cytology, colposcopy and DNA hybridisation as methods of detection. Genitourin Med. 1991;67:21-5.
15. Mahdavi A, Monk BJ. Vaccines against human papillomavirus and cervical cancer: promises and challenges. Oncologist. 2005;10:528-38.
16. Sonnex C, Scholefield JH, Kocjan G, Kelly G, Whatrup C, Mindel A, et al. Anal human papillomavirus infection in heterosexuals with genital warts: prevalence and relation with sexual behaviour. BMJ. 1991;303:1243.
17. Goorney BP, Waugh MA, Clarke J. Anal warts in heterosexual men. Genitourin Med. 1987;63:216.
18. Lacey CJ. Therapy for genital human papillomavirus-related disease. J Clin Virol. 2005;32 Suppl 1:82-90.
19. Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Perianal Bowen's disease and anal intraepithelial neoplasia: review of the literature. Dis Colon Rectum. 1999;42:945-51.
20. Smith JH. Bethesda 2001. Cytopathology. 2002;13:4-10.
21. Lytwyn A, Salit IE, Raboud J, Chapman W, Darragh T, Winkler B, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer. 2005;103:1447-56.
22. Foust RL, Dean PJ, Stoler MH, Moinuddin SM. Intraepithelial neoplasia of the anal canal in hemorrhoidal tissue: a study of 19 cases. Hum Pathol. 1991;22:528-34.
23. Patel HS, Silver AR, Northover JM. Anal cancer in renal transplant patients. Int J Colorectal Dis. 2005;16:1-5.
24. Pera M, Sugranes G, Ordi J, Trias M. Asociación entre la infección por el virus del papiloma humano, las lesiones premalignas del cáncer anal y el virus de la inmunodeficiencia humana: estudio prospectivo en individuos con condilomas acuminados. Med Clin (Barc). 1999;113:13-4.
25. Scholefield JH, Hickson WG, Smith JH, Rogers K, Sharp F. Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet. 1992;340:1271-3.
26. Mullerat J, Deroide F, Winslet MC, Perrett CW. Proliferation and p53 expression in anal cancer precursor lesions. Anticancer Res. 2003;23:2995-9.
27. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis. 2001;183:383-91.
28. Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 2003;138:453-9.
29. Melbye M, Palefsky J, Gonzales J, Ryder LP, Nielsen H, Bergmann O, et al. Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int J Cancer. 1990;46:203-6.
30. Linger ER, Vernon SD, Lee DR, Miller DL, Sharma S, Clancy KA, et al. Human papillomavirus type in anal epithelial lesions is influenced by human immunodeficiency virus. Arch Pathol Lab Med. 1997;121:820-4.
31. Mandelblatt JS, Kanetsky P, Eggert L, Gold K. Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev. 1999;8:97-106.
32. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst. 2001;93:843-9.
33. Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, DaCosta MM, Botts R, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:314-9.
34. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS. 1998;12:495-503.
35. Palefsky JM, Holly EA, Efirdc JT, Da Costa M, Jay N, Berry JM, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS. 2005;19:1407-14.
36. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Bonner H, Jay N, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr. 2001;28:422-8.
37. Gagne SE, Jensen R, Polvi A, Da Costa M, Ginzinger D, Efird JT, et al. High-resolution analysis of genomic alterations and human papillomavirus integration in anal intraepithelial neoplasia. J Acquir Immune Defic Syndr. 2005;40:182-9.
38. Snijders PJ, Van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol. 2003;201:1-6.
39. Mullerat J, Wong Te Fong LF, Davies SE, Winslet MC, Perrett CW. Angiogenesis in anal warts, anal intraepithelial neoplasia and anal squamous cell carcinoma. Colorectal Dis. 2003;5:353-7.
40. Litle VR, Leavenworth JD, Darragh TM, Kosinski LA, Moore DH, Smith-McCune KK, et al. Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesions. Dis Colon Rectum. 2000;43:346-52.
41. Mullerat J, Perrett CW, Deroide F, Winslet MC, Bofill M, Poulters LW. The role of macrophages in angiogenesis. Comparison between HIV+ and HIV- populations with anal dysplasia and anal cancer. Anticancer Res. 2005;25:693-9.
42. Billingham RP, Isler JT, Kimmins MH, Nelson JM, Schweitzer J, Murphy MM. The diagnosis and management of common anorectal disorders. Curr Probl Surg. 2004;41:586-645.
43. Scholefield JH, Ogunbiyi OA, Smith JH, Rogers K, Sharp F. Anal colposcopy and the diagnosis of anal intraepithelial neoplasia in high-risk gynecologic patients. Int J Gynecol Cancer. 1994;4:119-26.
44. Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum. 2002;45:453-8.
45. Haye KR, Maiti H, Stanbridge CM. Cytolpgical screening to detect subclinical anal human papillomavirus (HPV) infection in homosexual men attending genitourinary medicine clinic. Genitourin Med. 1988;64:378-82.
46. Frazer IH, Medley G, Crapper RM, Brown TC, Mackay IR. Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet. 1986;2:657-60.
47. Fox PA, Seet JE, Stebbing J, Francis N, Barton SE, Strauss S, et al. The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect. 2005;81:142-6.
48. Vajdic CM, Anderson JS, Hillman RJ, Medley G, Grulich AE. Blind sampling is superior to anoscope guided sampling for screening for anal intraepithelial neoplasia. Sex Transm Infect. 2005;81:415-8.
49. Yamaguchi T, Moriya Y, Fujii T, Kondo H, Oono Y, Shimoda T. Anal canal squamous-cell carcinoma in situ, clearly demonstrated by indigo carmine dye spraying: report of a case. Dis Colon Rectum. 2000;43:1161-3.
50. Zielinski GD, Bais AG, Heimerhorst TJ, Verheijen RH, De Schipper FA, Snijders PJ, et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv. 2004;59:543-53.
51. Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC. Perianal Bowen's disease: a clinicopathologic study of 47 patients. Dis Colon Rectum. 1997;40:1286-93.
52. Devaraj B, Cosman BC. Expectant management of anal squamous dysplasia in patients with HIV. Dis Colon Rectum. 2006;49:36-40.
53. Sarmiento JM, Wolff BG, Burgart LJ, Frizelle FA, Ilstrup DM. Perianal Bowen's disease: associated tumors, human papillomavirus, surgery, and other controversies. Dis Colon Rectum. 1997;40:912-8.
54. Klencke B, Matijevic M, Urban RG, Lathey JL, Hedley ML, Berry M, et al. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a phase I study of ZYC101. Clin Cancer Res. 2002;8:1028-37.
55. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364:1757-65.
56. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6:271-8.
57. Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Treatment options for perianal Bowen's disease: survery of American Society of Colon and Rectal Surgeons Members. Am Surg. 2000;66:686-8.
58. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999;281:1822-9.